Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans - PubMed
Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
Silke Vogelgesang et al. Pharmacogenetics. 2002 Oct.
Abstract
Deposition of the beta-amyloid peptide (Abeta) in the brain occurs during normal ageing and is substantially accelerated in patients with Alzheimer's disease. Since Abeta is continuously produced in the brain, it has been suggested that a clearance mechanism should exist to prevent its accumulation and subsequent aggregation. Until now, little attention has been paid to the possible role of P-glycoprotein (P-gp), a member of the ATP binding cassette superfamily of transporter proteins, in the pathogenesis of Alzheimer's disease. A recent study demonstrated that Abeta40 and Abeta42 interact directly with P-gp. We therefore hypothesized that Abeta accumulation in the brain would correlate inversely with the degree of vascular P-gp expression. To study early pathogenetic factors that influence the deposition of Abeta, at routine autopsies, brain tissue samples were taken from 243 non-demented subjects who died between the ages of 50 and 91 years. Vascular P-gp expression and the number of Abeta40- and Abeta42-positive senile plaques were assessed immunohistochemically in the medial temporal lobe. In addition, the apolipoprotein E (apoE) genotypes, as well as multiple drug resistance gene 1 ( ) polymorphisms (exon 2, G-1A; exon 21, G2677T/A; exon 26, C3436T), were also determined for each case. P-gp expression was not correlated with genotypes, but we found a significant inverse correlation between P-gp expression and the deposition of both Abeta40 and Abeta42 in the medial temporal lobe. Our results provide the first evidence in human brain tissue that the accumulation of Abeta may be influenced by the expression of P-gp in blood vessels, and suggest that P-gp may influence the elimination of Abeta from brain.
Similar articles
-
Vogelgesang S, Warzok RW, Cascorbi I, Kunert-Keil C, Schroeder E, Kroemer HK, Siegmund W, Walker LC, Pahnke J. Vogelgesang S, et al. Curr Alzheimer Res. 2004 May;1(2):121-5. doi: 10.2174/1567205043332225. Curr Alzheimer Res. 2004. PMID: 15975076 Free PMC article.
-
Bruckmann S, Brenn A, Grube M, Niedrig K, Holtfreter S, von Bohlen und Halbach O, Groschup M, Keller M, Vogelgesang S. Bruckmann S, et al. Curr Alzheimer Res. 2017;14(6):656-667. doi: 10.2174/1567205013666161201201227. Curr Alzheimer Res. 2017. PMID: 27915995
-
Pahnke J, Walker LC, Schroeder E, Vogelgesang S, Stausske D, Walther R, Warzok RW. Pahnke J, et al. Acta Neuropathol. 2003 Jan;105(1):25-9. doi: 10.1007/s00401-002-0602-0. Epub 2002 Nov 5. Acta Neuropathol. 2003. PMID: 12471457
-
P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
Chai AB, Leung GKF, Callaghan R, Gelissen IC. Chai AB, et al. FEBS J. 2020 Feb;287(4):612-625. doi: 10.1111/febs.15148. Epub 2019 Dec 9. FEBS J. 2020. PMID: 31750987 Review.
-
Vogelgesang S, Jedlitschky G, Brenn A, Walker LC. Vogelgesang S, et al. Curr Pharm Des. 2011;17(26):2778-86. doi: 10.2174/138161211797440168. Curr Pharm Des. 2011. PMID: 21827406 Review.
Cited by
-
Blood-brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy.
Lau K, Kotzur R, Richter F. Lau K, et al. Transl Neurodegener. 2024 Jul 29;13(1):37. doi: 10.1186/s40035-024-00430-z. Transl Neurodegener. 2024. PMID: 39075566 Free PMC article. Review.
-
Storelli F, Billington S, Kumar AR, Unadkat JD. Storelli F, et al. Clin Pharmacol Ther. 2021 Mar;109(3):667-675. doi: 10.1002/cpt.2035. Epub 2020 Oct 6. Clin Pharmacol Ther. 2021. PMID: 32885413 Free PMC article.
-
Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.
Andreev VP, Petyuk VA, Brewer HM, Karpievitch YV, Xie F, Clarke J, Camp D, Smith RD, Lieberman AP, Albin RL, Nawaz Z, El Hokayem J, Myers AJ. Andreev VP, et al. J Proteome Res. 2012 Jun 1;11(6):3053-67. doi: 10.1021/pr3001546. Epub 2012 May 17. J Proteome Res. 2012. PMID: 22559202 Free PMC article.
-
Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM. Cirrito JR, et al. J Clin Invest. 2005 Nov;115(11):3285-90. doi: 10.1172/JCI25247. Epub 2005 Oct 20. J Clin Invest. 2005. PMID: 16239972 Free PMC article.
-
Boston-Howes W, Williams EO, Bogush A, Scolere M, Pasinelli P, Trotti D. Boston-Howes W, et al. Exp Neurol. 2008 Sep;213(1):229-37. doi: 10.1016/j.expneurol.2008.06.010. Epub 2008 Jun 24. Exp Neurol. 2008. PMID: 18625223 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous